
Incyte Corp
INCYHealthcare|Biotechnology|USA
$93.59
-1.27 (-1.34%)
DCF (FCF)
$55.64
Tangible Book
$24.78
Graham Number
$61.53
Earnings Power
$50.38
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
5568.56,
6180.18,
6360.68
],
"ebit_estimate": [
1877.79,
2349.66,
2542.99
],
"ebitda_estimate": [
1863.43,
2448.34,
2650.59
],
"net_income_estimate": [
1552.81,
1913.32,
1984.25
],
"per_share_eps_estimate": [
6.42,
7.5,
7.83
],
"eps_nri_estimate": [
7.59,
8.96,
9.28
],
"dividend_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
33.47,
42.93,
53.23
],
"pretax_income_estimate": [
1967.18,
2530.43,
2741.52
],
"operating_cash_flow_per_share_estimate": [
8.57,
9.89,
10.6
],
"roa_estimate": [
16,
14.63,
10.75
],
"roe_estimate": [
22.69,
21.19,
17.65
],
"gross_margin_estimate": [
92.51,
92.37,
92.01
],
"operating_cash_flow_estimate": [
1753.29,
2023.35,
2168.6
],
"pettm_estimate": [
14.6,
12.49,
11.96
],
"long_term_growth_rate_mean": 11.62,
"long_term_revenue_growth_rate_mean": "7.71",
"future_per_share_eps_estimate_growth": 7.87,
"future_eps_nri_estimate_growth": 11.62,
"future_revenue_estimate_growth": 7.71,
"future_ebit_estimate_growth": 16.08,
"future_ebitda_estimate_growth": 16.2,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 16.28,
"future_pretax_income_estimate_growth": 19.11,
"future_book_value_per_share_estimate_growth": 27.05,
"future_roa_estimate_growth": -18.63,
"future_roe_estimate_growth": -15.18,
"future_gross_margin_estimate_growth": -0.26,
"future_operating_cash_flow_per_share_estimate_growth": 14.68
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
1233.07,
1361.51,
1443.4,
1538.88,
1369.41,
1466.14,
1516.8,
1589.01
],
"ebit_estimate": [
349.74,
449.56,
501.66,
556.68,
499.06,
567.52,
583.72,
618.74
],
"ebitda_estimate": [
249.96,
391.67,
514.94,
628.39,
null,
null,
null,
null
],
"net_income_estimate": [
283.59,
369.59,
423.96,
466.28,
406.61,
459.32,
471.8,
498.76
],
"per_share_eps_estimate": [
1.1,
1.56,
1.76,
1.91,
null,
null,
null,
null
],
"eps_nri_estimate": [
1.44,
1.83,
2.08,
2.23,
1.96,
2.21,
2.4,
2.83
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
373.24,
479.01,
541.08,
587.73,
528.06,
596.52,
612.72,
647.74
],
"operating_cash_flow_per_share_estimate": [
1.18,
1.76,
2.26,
2.71,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
92.52,
92.74,
92.5,
92.38,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
241.41,
360.07,
462.36,
554.43,
null,
null,
null,
null
],
"pettm_estimate": [
14.83,
null,
null,
null,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 11.62,
"long_term_revenue_growth_rate_mean": "7.71",
"future_per_share_eps_estimate_growth": 7.87,
"future_eps_nri_estimate_growth": 11.62,
"future_revenue_estimate_growth": 7.71,
"future_ebit_estimate_growth": 16.08,
"future_ebitda_estimate_growth": 16.2,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 16.28,
"future_pretax_income_estimate_growth": 19.11,
"future_book_value_per_share_estimate_growth": 27.05,
"future_roa_estimate_growth": -18.63,
"future_roe_estimate_growth": -15.18,
"future_gross_margin_estimate_growth": -0.26,
"future_operating_cash_flow_per_share_estimate_growth": 14.68
}